MedPath

The Impact of a Topical Vasodilating Cream on Female Sexual Experience

Conditions
Female Sexual Dysfunction
Registration Number
NCT01078077
Lead Sponsor
Michael Pelekanos MD
Brief Summary

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Detailed Description

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Healthy females ages 25 to sixty sexually active
Exclusion Criteria
  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

West Penn Allegheny Health Center

🇺🇸

Monroeville, Pennsylvania, United States

West Penn Hospital Forbes Campus

🇺🇸

Monroeville, Pennsylvania, United States

East Suburban Obgyn

🇺🇸

Monroeville, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath